The Company has filed data with FDA that documents the long-term stability and sterility of preservative-free ketamine for intravenous use WILMINGTON, Del., Aug. 4, 2025 /PRNewswire/ -- NRx ...
NRx Pharmaceuticals (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride From Ketamine Products
LOS ANGELES, CA - August 13, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has filed a Citizen Petition with the FDA requesting the removal of ...
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in ...
WILMINGTON, Del., Aug. 4, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, today announced the filing of a Citizen Petition with the US Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results